73-32-5
73-32-5
Chemical Structure
L-Isoleucine
- CAS No.: 73-32-5
- Formula:C6H13NO2
- Molecular Weight:131.18
IUPAC Name: L-isoleucine
InChIKey: AGPKZVBTJJNPAG-WHFBIAKZSA-N
SMILES: N[C@@H]([C@@H](C)CC)C(O)=O
Biological Activity: L-Isoleucine is an orally active branched chain amino acid, which is the L-enantiomer of isoleucine. L-Isoleucine has a role as a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. L-Isoleucine regulates the inflammatory response to protect against pathogens in vivo and in vitro[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
L-Isoleucine | 99.91% | L-Isoleucine is an orally active branched chain amino acid, which is the L-enantiomer of isoleucine. L-Isoleucine has a role as a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. L-Isoleucine regulates the inflammatory response to protect against pathogens in vivo and in vitro. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine (Standard) | 97.26% | L-Isoleucine (Standard) is the analytical standard of L-Isoleucine. This product is intended for research and analytical applications. L-Isoleucine is an orally active branched chain amino acid, which is the L-enantiomer of isoleucine. L-Isoleucine has a role as a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite, a plant metabolite, a human metabolite, an algal metabolite and a mouse metabolite. L-Isoleucine regulates the inflammatory response to protect against pathogens in vivo and in vitro. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Isoleucine-d10 | 98.6% | DL-Isoleucine-d10 is the deuterium labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-d10 | 99.89% | L-Isoleucine-d10 is the deuterium labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-15N,d10 | 98.0% | L-Isoleucine-15N,d10 is the deuterium and 15N-labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-13C6,15N | 98.0% | L-Isoleucine-13C6,15N is 13C and 15N labeled L-isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-15N | 99.86% | L-Isoleucine-15N is the 15N-labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-13C6,15N,d10 | 99.9% | L-Isoleucine-13C6,15N,d10 is the deuterium, 13C-, and 15-labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-d | 99.48% | L-Isoleucine-d is the deuterium labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-1-13C | 99.99% | L-Isoleucine-1-13C is the 13C-labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Isoleucine-13C6 | 99.77% | L-Isoleucine-13C6 is the 13C-labeled L-Isoleucine. L-isoleucine is a nonpolar hydrophobic amino acid. L-Isoleucine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Alloisoleucine | 98.0% | D-Alloisoleucine is an isoleucine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(±)-Leucine-d10 | 98.0% | (±)-Leucine-d10 is the deuterium labeled (±)-Leucine. (±)-Leucine (DL-Leucine), an isomer of Leucine, chemosterilant and dietary additive. (±)-Leucine inhibits growth of Escherichia coli HfrH by 92.08%. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Alloisoleucine | 98.0% | L-Alloisoleucine is a stereoisomer of L-isoleucine. L-Alloisoleucine can be used in skeletal muscle research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Alloisoleucine (Standard) | ≥98% | L-Alloisoleucine (Standard) is the analytical standard of L-Alloisoleucine. This product is intended for research and analytical applications. L-Alloisoleucine is a stereoisomer of L-isoleucine. L-Alloisoleucine can be used in skeletal muscle research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Alloisoleucine-d10 | L-Alloisoleucine-d10 is the deuterium labeled L-Alloisoleucine. L-Alloisoleucine is a branched chain amino acid and is a stereo-isomer of L-isoleucine. L-Alloisoleucine is a common constituent of human plasma (albeit at low levels). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Isoleucine | 99.83% | D-Isoleucine is a selective competitive activator of the Asc-1 antiporter (Ki=0.98 mM). D-Isoleucine promotes the release of D-serine and glycine by binding to the Asc-1 protein on the neuronal cell membrane, and enhances NMDA receptor-dependent synaptic plasticity. D-Isoleucine can be used in the study of neurodegenerative diseases (such as Alzheimer's disease and schizophrenia). D-Isoleucine also acts as a non-classical D-amino acid, interferes with bacterial peptidoglycan synthesis, and inhibits the formation of Staphylococcus aureus biofilm, and has potential antibacterial application value. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Valine-d8 | 99.91% | L-Valine-d8 is a deuterated form of L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Leucine-d10 | 99.0% | L-Leucine-d10 is the deuterium labeled L-Leucine. L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Valine-d8 | 99.09% | D-Valine-d8 is the deuterium labeled D-Valine. D-Valine is the enantiomer of L-Valine (HY-N0717). L-Valine is one of 20 proteinogenic amino acids. L-Valine is an essential amino acid. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
L-Valine-13C5,15N,d8 | L-Valine-13C5,15N,d8 ((S)-Valine-13C5,15N,d8) is the deuterium, 13C-, and 15N-labeled L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Isoleucine | 99.43% | DL-Isoleucine is an isoleucine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
DL-Valine-d8 | 99.96% | DL-Valine-d8 is the deuterium labeled DL-Valine. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(rac)-Isoleucine | 98.0% | (rac)-Isoleucine is the racemic form of Isoleucine. Isoleucine is a mixture of the diastereomers L-isoleucine, L-alloisoleucine, D-isoleucine, and D-alloisoleucine. L-isoleucine is a branched-chain amino acid that acts as a nitrogen donor, and has roles in glucose consumption, fatty acid metabolism, as well as immune function. L-Alloisoleucine is generated by transamination of L-isoleucine. D-Isoleucine and D-alloisoleucine are enantiomers of L-isoleucine and L-alloisoleucine, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(S)-2-Amino-3-ethylpentanoic acid | (S)-2-Amino-3-ethylpentanoic acid (L-β,β-Diethylalanine) is a non-natural amino acid that can be used in research on structural units and building blocks for peptide drugs. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
D-Leucine-d10 | 99.96% | D-Leucine-d10 is the deuterium labeled D-Leucine. D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
